This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Lip
CD2_BENIGN_LIP_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10
- Name in latin
- Neoplasma benignum labii (oris)
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Lip
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Lip
- Benign neoplasm of mouth and pharynx
- Benign neoplasm of mouth and pharynx
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 776 | 391 | 385 |
| Unadjusted period prevalence (%) | 0.15 | 0.13 | 0.17 |
| Median age at first event (years) | 59.23 | 55.57 | 62.95 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 710
- Matched controls
- 7101
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D10.09
ICD-10 Finland
Benign tumor of the lip UNS
+∞
271.9
243
*
EAA10
NOMESCO Finland
Excision of lesion of lip
215.1
213.4
212
14
D10.04
ICD-10 Finland
Lower lip tumor in the lower lip mucosa
+∞
196.2
179
*
D10.00
ICD-10 Finland
Upper lip tumor in upper lip on lip lip border
+∞
114.8
107
*
TEA00
NOMESCO Finland
Biopsy of lip
56.2
67.9
80
16
D10.01
ICD-10 Finland
Uper lip tumor in the upper lip mucosa
+∞
64.6
61
*
D10.03
ICD-10 Finland
Lower lip tumor in the lower lip at the lip red border
+∞
52.8
50
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
522.8
50.0
49
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
46.4
44
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
9.4
45.2
97
117
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
42.1
40
*
130
Kela drug reimbursment
Malignant tumour
+∞
41.0
39
*
D10.0
ICD-10 Finland
Benign neoplasm: Lip
+∞
38.9
37
*
115
Kela drug reimbursment
Breast cancer
+∞
35.7
34
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
100.2
35.1
38
*
21000
ICD-8 Finland
Benign neoplasm of buccal cavity and pharynx, Lip
+∞
34.7
33
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
33.6
32
*
8070/3-C00.1
ICD-O-3
Squamous cell carcinoma, NOS, of external lower lip
+∞
32.5
31
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
30.4
29
*
2100A
ICD-9 Finland
Benign neoplasm of lip, oral cavity and pharynx, Lip
+∞
28.3
27
*
116
Kela drug reimbursment
Prostate cancer
+∞
27.3
26
*
C44.02
ICD-10 Finland
Spinocellular carcinoma of the lip skin
+∞
25.1
24
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
15.1
24.2
40
28
C00.1
ICD-10 Finland
Malignant neoplasm: External lower lip
+∞
24.1
23
*
H02AB02
ATC
dexamethasone; systemic
15.5
22.7
37
25
A04AA02
ATC
granisetron; systemic, transdermal
+∞
22.0
21
*
EAA30
NOMESCO Finland
Partial excision of lower lip
+∞
22.0
21
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
226.6
21.7
22
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
18.8
18
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
18.8
18
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
18.8
18
*
HAC20
NOMESCO Finland
Total mastectomy
194.9
18.6
19
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
54.0
18.0
21
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
17.8
17
*
A03FA01
ATC
metoclopramide; systemic, rectal
3.0
17.3
110
414
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
11.1
16.6
31
29
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
173.9
16.6
17
*
L57.0
ICD-10 Finland
Actinic keratosis
3.5
15.9
76
232
4381
FHL
Exemption of local change
61.4
15.8
18
*
L02AE02
ATC
leuprorelin; implant, parenteral
34.2
15.8
20
6
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
15.7
15
*
D10.05
ICD-10 Finland
Lower lip tumor in lower lip mucosa and on lip lip border
+∞
15.7
15
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
15.7
15
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
14.6
14
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
14.6
202
1134
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
153.0
14.5
15
*
L02BG04
ATC
letrozole; oral
11.7
14.4
26
23
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.3
13.8
51
125
ZX090
NOMESCO Finland
Other technic of radiotherapy
76.6
13.6
15
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
13.6
13
*
TQW99
NOMESCO Finland
Other minor procedure on skin
4.7
12.1
41
92
WF002
NOMESCO Finland
Radical radiotherapy
47.5
11.9
14
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
47.5
11.9
14
*
JN4BD
NOMESCO Finland
Extensive body CT
3.6
11.7
53
156
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
19.3
11.6
17
9
Y77
ICPC
Malignant neoplasm prostate
+∞
11.5
11
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
11.5
11
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
11.5
11
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
11.5
11
*
L02BB03
ATC
bicalutamide; oral
121.9
11.5
12
*
JN4AD
NOMESCO Finland
Body CT examination
5.1
11.3
35
72
D18.0
ICD-10 Finland
Haemangioma, any site
5.9
11.0
30
53
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.4
10.7
31
59
SPAT1153
SPAT
Removal of sutures
1.8
10.7
219
1395
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
6.7
10.6
26
40
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
111.6
10.4
11
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
10.4
10
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
10.4
10
*
C00.9
ICD-10 Finland
Malignant neoplasm: Lip, unspecified
+∞
10.4
10
*
L01BC06
ATC
capecitabine; oral
+∞
10.4
10
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
10.4
10
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
10.4
287
2006
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.1
10.1
127
675
HA1AA
NOMESCO Finland
X-ray mammography
4.6
10.1
34
77
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
10.0
128
682
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
4.6
9.8
33
75
D20
ICPC
Mouth/tongue/lip symptom/complaint
3.5
9.8
44
130
S18
ICPC
Laceration/cut
1.7
9.6
276
1938
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
9.4
9
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
9.4
9
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
9.4
9
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
9.4
9
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
9.4
9
*
Z51.5
ICD-10 Finland
Palliative care
5.2
9.3
28
56
A02BC02
ATC
pantoprazole; systemic
1.6
9.0
417
3314
L02BA01
ATC
tamoxifen; oral
37.2
9.0
11
*
N02AX02
ATC
tramadol; systemic, rectal
1.6
8.7
273
1950
XX3DW
NOMESCO Finland
Time consuming IT work
3.4
8.6
40
122
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.2
8.5
25
49
D23.0
ICD-10 Finland
Benign neoplasm: Skin of lip
20.3
8.5
12
6
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
4.0
8.4
32
82
L03AA13
ATC
pegfilgrastim; parenteral
91.1
8.4
9
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
91.1
8.4
9
*
X76
ICPC
Malignant neoplasm breast female
+∞
8.3
8
*
L02BG03
ATC
anastrozole; oral
+∞
8.3
8
*
A04AD12
ATC
aprepitant; systemic
+∞
8.3
8
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
8.3
8
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
8.3
8
*
JN4CD
NOMESCO Finland
Very extensive body CT
5.6
8.3
23
42
K11.69
ICD-10 Finland
Mukocele UNS
14.7
8.2
13
9
WZC30
NOMESCO Finland
Teaching
2.4
8.2
73
329
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
4.6
7.9
26
58
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.1
7.9
42
142
R23.8
ICD-10 Finland
Other and unspecified skin changes
2.1
7.8
95
497
J01DB01
ATC
cefalexin; oral
1.6
7.6
541
4688
R01AD09
ATC
mometasone; nasal
1.6
7.6
278
2048
D83
ICPC
Mouth/tongue/lip disease
12.0
7.6
13
11
SXA10
NOMESCO Finland
Epithel biopsy of mouth
7.2
7.5
17
24
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
80.9
7.4
8
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
80.9
7.4
8
*
K13.78
ICD-10 Finland
Other change in the oral mucosa
5.7
7.4
20
36
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
7.3
7
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
7.3
7
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
7.3
7
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
7.3
7
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
7.3
7
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.5
7.3
57
243
N05CF01
ATC
zopiclone; oral
1.6
7.2
217
1518
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
7.2
157
1006
K13.03
ICD-10 Finland
Keilit UNS
20.2
7.1
10
5
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
5.9
6.9
18
31
D06BB10
ATC
imiquimod; topical
3.4
6.9
31
93
K13.09
ICD-10 Finland
Disease of the lips UNS
40.4
6.8
8
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.0
6.7
36
123
UKC02
NOMESCO Finland
Cystoscopy
1.9
6.7
102
577
K11.6
ICD-10 Finland
Mucocele of salivary gland
22.7
6.7
9
*
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
22.7
6.7
9
*
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
6.6
88
477
SAA02
NOMESCO Finland
Basic examination of mouth
1.5
6.6
395
3228
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
2.9
6.5
37
131
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
70.4
6.4
7
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
6.4
192
1337
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.5
6.4
21
48
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
5.6
6.3
17
31
EKB00
NOMESCO Finland
Excision of lesion of cheek
11.1
6.3
11
10
H02AB07
ATC
prednisone; oral
1.9
6.3
99
571
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
+∞
6.3
6
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
6.3
6
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
6.3
6
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
6.3
6
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
6.3
6
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
6.3
6
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
6.3
6
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
6.3
6
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
6.3
6
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
6.3
6
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
6.3
6
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
6.3
6
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
6.3
6
*
C00.0
ICD-10 Finland
Malignant neoplasm: External upper lip
+∞
6.3
6
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
6.3
6
*
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
26.9
6.2
8
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
26.9
6.2
8
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
26.9
6.2
8
*
EKA10
NOMESCO Finland
Biopsy of cheek
4.0
6.2
23
59
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.4
6.2
51
225
H04.10
ICD-10 Finland
Dry eye syndrome
2.1
6.1
66
329
N02AA05
ATC
oxycodone; systemic
2.0
6.0
80
430
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
6.0
176
1211
ZXC50
NOMESCO Finland
Cryotherapy
4.6
6.0
19
42
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
91
291
3.41
23.51
2.6
1.5
4.4
3.8
ug/l
0.15
67
220
366
2597
1.77
13.54
5.2
4.9
1.2
1.2
mmol/l
0.14
305
2289
557
4476
1.87
13.44
7.9
5.3
79.4
75.6
u/l
0.89
518
4126
391
2849
1.75
13.01
5.9
5.3
1.2
1.2
mmol/l
0.02
323
2414
421
3167
1.72
12.20
8.8
6.4
3.9
4.3
e9/l
3.73
365
2762
272
1872
1.70
10.53
3.0
2.0
2.4
2.4
mmol/l
0.32
220
1546
106
548
2.08
10.15
3.6
2.8
219.0
237.6
u/l
1.16
94
508
141
809
1.91
10.04
4.5
4.8
35.5
32.6
%
1.90
79
532
376
2842
1.63
9.94
6.2
3.6
11.9
11.5
umol/l
0.16
350
2653
200
1299
1.73
9.40
2.5
2.0
—
—
—
0
0
342
2573
1.59
8.90
4.0
3.6
—
—
—
0
0
35
120
3.01
8.06
3.1
1.9
459.7
109.7
u/ml
0.86
28
95
438
3536
1.55
8.06
4.6
4.1
6.9
6.8
mmol/l
0.21
409
3288
316
2433
1.50
6.90
4.7
3.6
35.5
35.6
g/l
0.13
286
2241
527
4515
1.52
6.74
4.9
4.1
12.9
11.9
mm/h
0.84
464
4121
52
239
2.26
6.69
1.8
1.7
—
—
—
0
0
25
80
3.20
6.49
1.1
1.2
—
—
—
0
0
128
812
1.69
6.37
8.2
6.8
—
—
—
0
0
423
3494
1.46
6.28
2.7
2.8
—
—
—
0
0
14
30
4.73
6.23
2.6
1.3
13.9
14.7
ug/l
0.13
14
30
99
591
1.77
6.11
2.7
2.3
7.7
7.5
umol/l
0.04
88
518
143
952
1.62
5.88
1.8
1.7
—
—
—
0
0
609
5451
1.54
5.75
18.2
13.5
39.8
40.1
%
0.37
388
3720
18
51
3.59
5.63
1.6
1.4
13.9
28.9
u/l
1.16
11
35
21
66
3.24
5.63
1.7
1.1
—
—
—
0
0
659
6018
1.63
5.58
17.1
12.4
22.7
23.1
mg/l
0.13
543
4663
47
224
2.17
5.57
1.6
1.6
—
—
—
0
0
21
67
3.19
5.50
1.7
1.1
—
—
—
0
0
21
67
3.19
5.50
1.7
1.1
—
—
—
0
0
328
2629
1.43
5.46
2.2
2.0
94.7
95.3
pmol/l
0.08
158
1350
21
68
3.15
5.37
1.7
1.1
—
—
—
0
0
21
68
3.15
5.37
1.7
1.1
—
—
—
0
0
21
68
3.15
5.37
1.7
1.1
—
—
—
0
0
129
862
1.60
5.20
24.8
25.7
1.3
1.4
inr
0.10
18
120
448
3851
1.39
4.71
3.2
3.0
47.7
45.9
u/l
0.19
405
3563
202
1521
1.44
4.59
2.4
2.2
2.9
3.0
mg/l
0.19
156
1265
260
2073
1.38
4.21
3.5
3.0
—
—
—
0
0
72
439
1.71
4.15
3.6
1.6
66.5
67.5
g/l
0.45
56
392
235
1851
1.39
4.07
2.6
2.2
60.2
57.4
u/l
0.51
210
1689
107
726
1.55
4.02
2.5
2.4
22.6
23.8
%
0.40
86
619
115
795
1.52
3.97
2.4
2.3
2.3
2.3
g/l
0.07
102
732
614
5642
1.42
3.86
5.5
4.6
1.9
2.2
mu/l
0.62
535
5125
299
2464
1.35
3.85
2.4
2.3
77.3
77.9
nmol/l
0.13
245
2158
116
819
1.49
3.63
3.8
2.4
0.8
0.8
mmol/l
0.17
103
757
676
6350
1.50
3.54
19.7
14.7
139.7
139.8
mmol/l
0.49
652
6170
678
6373
1.51
3.54
19.8
14.8
4.0
4.0
mmol/l
1.75
651
6184
76
491
1.61
3.53
3.5
2.1
36.0
32.6
u/l
0.33
58
400
10
26
3.88
3.53
6.6
2.1
2.9
3.7
nmol/l
—
10
26
82
544
1.57
3.42
3.0
3.0
122.6
223.8
ng/l
4.18
71
506
618
5724
1.39
3.38
15.7
11.2
78.4
79.0
ml/min/173m2
0.26
513
4598
43
242
1.82
3.30
1.4
1.6
1.4
1.5
g/l
0.41
35
209
26
122
2.17
3.29
1.8
1.2
—
—
—
0
0
130
960
1.43
3.22
2.9
2.6
1.4
1.1
e6/l
0.30
67
547
37
201
1.88
3.17
2.5
1.4
11.6
11.0
g/l
0.20
24
168
160
1229
1.38
3.15
1.9
1.7
1086.8
1165.8
nmol/l
0.42
100
921
35
187
1.91
3.15
3.5
1.5
14.5
23.4
u/ml
1.01
35
179
43
246
1.79
3.14
3.5
3.9
25.0
24.9
mmol/l
0.07
35
227
688
6519
1.49
3.10
12.1
8.8
27.8
26.1
u/l
0.68
657
6235
145
1099
1.39
3.09
2.7
2.1
2.5
2.4
mmol/l
1.40
128
938
39
218
1.83
3.07
3.4
1.4
7.7
7.6
g/l
0.14
22
159
39
218
1.83
3.07
3.4
1.4
—
—
—
0
0
39
218
1.83
3.07
3.4
1.4
3.9
3.9
g/l
0.07
21
155
196
1572
1.33
2.91
3.5
2.8
0.3
0.4
e6/l
0.31
142
1192
61
393
1.60
2.90
3.9
3.5
4.9
5.2
kpa
1.54
54
368
193
1549
1.33
2.85
1.7
1.5
21.6
20.5
nmol/l
0.36
149
1315
103
746
1.44
2.84
4.7
4.5
1.0
1.0
mmol/l
1.11
86
670
296
2518
1.28
2.83
3.1
2.7
144.1
116.9
ug/l
0.54
258
2291
121
905
1.40
2.79
3.0
2.8
3.4
2.1
e6/l
0.79
59
492
646
6078
1.38
2.79
5.1
4.7
6.0
6.0
mmol/l
0.16
558
5507
56
357
1.61
2.79
1.8
1.6
—
—
—
0
0
710
6795
1.53
2.78
25.5
18.3
134.5
136.2
g/l
2.24
695
6667
5
6
8.38
2.75
1.8
1.2
—
—
—
0
0
235
1947
1.30
2.74
2.3
2.1
179.3
245.9
u/l
0.82
213
1825
36
205
1.79
2.70
3.1
1.4
3.0
3.1
g/l
0.12
21
156
258
2168
1.28
2.69
5.5
3.8
4.1
2.0
ug/l
0.74
220
1928
10
32
3.15
2.65
1.8
1.3
—
—
—
0
0
118
891
1.38
2.58
2.5
2.2
13.0
13.5
umol/l
0.33
103
806
79
556
1.47
2.54
3.5
3.1
2.3
1.9
mmol/l
0.51
63
448
626
5885
1.33
2.53
4.3
4.1
1.3
1.3
mmol/l
0.28
537
5345
18
82
2.22
2.49
1.9
1.4
41.1
63.9
%
1.45
13
51
17
76
2.26
2.45
1.5
2.9
—
23.8
—
0
17
506
4639
1.26
2.44
4.4
3.8
14.9
14.8
pmol/l
0.05
424
4196
228
1908
1.28
2.42
3.1
2.9
1420.2
1485.8
ng/l
0.11
189
1601
661
6275
1.36
2.41
5.4
5.1
2.7
2.7
mmol/l
0.30
575
5748
31
175
1.80
2.41
1.6
1.3
—
—
—
0
0
161
1290
1.31
2.38
1.2
1.2
2.4
1.7
u/ml
0.21
31
350
8
22
3.66
2.37
2.0
1.2
—
—
—
0
0
8
22
3.66
2.37
2.0
1.2
—
—
—
0
0
31
177
1.78
2.33
1.8
1.3
36.9
37.8
g/l
0.26
17
146
56
374
1.54
2.32
3.1
2.2
11.3
14.8
nmol/l
1.89
46
328
7
18
3.91
2.25
2.1
1.2
—
—
—
0
0
7
18
3.91
2.25
2.1
1.2
—
—
—
0
0
215
1803
1.27
2.23
3.5
2.6
29.9
34.7
u/l
1.65
203
1713
648
6155
1.32
2.18
4.9
4.6
4.6
4.6
mmol/l
0.45
570
5662
150
1205
1.30
2.17
2.8
2.3
3.9
6.5
e6/l
2.18
131
1048
55
372
1.51
2.17
3.9
3.4
1.5
1.9
mmol/l
0.29
40
278
281
2439
1.24
2.14
4.2
3.7
43.0
59.0
ng/l
0.40
207
1717
13
55
2.39
2.13
1.5
1.3
4224.3
309153.0
e6/l
—
8
39
331
2925
1.23
2.13
3.2
3.6
0.0
0.0
estimate
0.00
40
498
20
102
1.99
2.12
2.0
1.7
—
—
—
0
0
80
586
1.41
2.11
2.7
2.5
5.8
7.1
ug/l
0.37
63
505
642
6099
1.30
2.09
5.0
4.6
1.4
1.5
mmol/l
0.38
561
5585
30
176
1.73
2.09
2.4
3.3
—
—
—
0
0
334
2959
1.23
2.08
3.3
3.6
0.0
0.0
estimate
0.80
40
487
330
2922
1.23
2.06
4.6
4.9
0.0
0.0
estimate
0.00
43
498
89
667
1.38
2.06
1.8
1.7
—
—
—
0
0
153
1244
1.29
2.02
1.7
1.6
1.1
1.1
mg/l
0.07
113
936
54
371
1.49
2.00
1.9
1.5
—
—
—
0
0
41
265
1.58
1.99
1.1
1.1
—
—
—
0
0
611
5788
1.26
1.91
6.4
6.1
40.3
40.2
mmol/mol
0.05
535
5342
27
160
1.71
1.84
1.4
1.4
—
—
—
0
0
72
532
1.39
1.83
2.9
1.8
360.6
366.5
nmol/l
0.09
65
483
26
153
1.72
1.81
1.6
1.4
254.9
313.0
ug/g
0.76
15
89
65
479
1.39
1.69
3.5
2.2
71.1
68.5
ml/min/173m2
0.21
32
208
24
142
1.71
1.66
1.7
1.6
339.7
291.8
mu/l
0.29
24
127
29
181
1.63
1.65
3.0
1.4
2.8
0.4
g/l
0.87
19
156
160
1348
1.24
1.57
1.9
1.7
430.9
9763202.4
pmol/l
0.80
116
1096
142
1182
1.25
1.55
5.4
3.9
61.6
363.0
ng/l
4.69
112
937
85
665
1.31
1.52
5.4
6.3
1.4
1.3
mmol/l
0.05
65
513
7
27
2.61
1.51
1.1
2.5
—
—
—
0
0
25
155
1.63
1.48
1.8
1.6
7178.4
13846.1
e6/l
0.81
18
118
7
28
2.51
1.45
5.4
2.4
—
—
—
0
0
5
16
3.14
1.44
2.6
1.1
—
—
—
0
0
5
16
3.14
1.44
2.6
1.1
—
—
—
0
0
5
16
3.14
1.44
2.6
1.1
—
—
—
0
0
19
110
1.75
1.44
5.1
3.6
4.9
5.1
kpa
0.37
19
110
6
22
2.74
1.43
2.5
1.2
0.6
1.3
mmol/l
—
6
22
184
1592
1.20
1.39
2.8
2.4
6553.4
6620.4
umol/l
0.01
148
1363
25
158
1.60
1.39
1.5
1.2
—
—
—
0
0
84
666
1.29
1.38
5.5
6.3
5.1
5.1
kpa
0.14
77
635
84
666
1.29
1.38
5.5
6.2
12.4
11.7
kpa
0.68
77
635
17
98
1.75
1.32
1.2
1.3
—
—
—
0
0
20
121
1.67
1.32
2.4
1.9
187.9
231.0
pmol/l
0.88
20
114
12
62
1.95
1.28
1.1
1.1
—
—
—
0
0
83
666
1.28
1.26
1.9
1.7
—
—
—
0
0
13
70
1.87
1.24
1.0
1.1
—
—
—
0
0
5
19
2.64
1.21
1.8
1.6
—
—
—
0
0
42
308
1.38
1.18
2.5
2.9
25.7
25.2
mmol/l
0.41
42
298
0
33
0.00
1.16
0.0
3.2
—
1242.3
—
0
33
12
65
1.86
1.14
1.0
1.1
138.4
117.4
%
—
7
60
18
111
1.64
1.13
1.7
1.4
—
—
—
0
0
11
58
1.91
1.12
1.8
1.3
—
—
—
0
0
10
51
1.97
1.11
1.9
1.4
—
—
—
0
0
57
444
1.31
1.10
2.1
1.9
—
—
—
0
0
20
129
1.56
1.06
1.2
1.3
—
—
—
0
0
33
237
1.41
1.06
1.8
2.1
40.8
39.1
u/l
0.21
26
206
5
22
2.28
1.03
2.6
1.1
—
—
—
0
0
5
22
2.28
1.03
2.6
1.1
—
—
—
0
0
5
22
2.28
1.03
2.6
1.1
—
—
—
0
0
5
22
2.28
1.03
2.6
1.1
—
—
—
0
0
20
130
1.55
1.03
1.3
1.4
—
—
—
0
0
30
216
1.40
0.97
2.0
1.7
0.9
1.4
ug/l
0.58
22
189
14
85
1.66
0.94
1.9
1.8
—
—
—
0
0
9
51
1.77
0.94
4.4
2.1
—
—
—
0
0
20
134
1.51
0.92
1.1
1.1
—
—
—
0
0
6
29
2.08
0.89
1.2
1.2
—
—
—
0
0
6
29
2.08
0.89
1.2
1.1
2.3
3.8
ug/l
—
6
24
8
42
1.91
0.88
1.5
1.0
—
—
—
0
0
8
137
0.58
0.84
1.5
1.5
—
—
—
0
0
8
46
1.75
0.82
1.1
1.2
—
—
—
0
0
8
46
1.75
0.82
1.1
1.2
—
—
—
0
0
14
89
1.58
0.81
1.0
1.2
0.6
0.6
nmol/l
0.05
14
82
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
17
115
1.49
0.77
1.7
1.4
—
—
—
0
0
57
469
1.23
0.76
3.3
3.6
76.9
88.1
ng/l
0.76
45
411
224
2059
1.12
0.76
3.0
3.1
7.3
7.6
mmol/l
0.30
171
1712
11
67
1.65
0.75
1.4
1.3
—
—
—
0
0
5
26
1.93
0.70
2.4
1.4
—
—
—
0
0
60
503
1.21
0.68
2.1
2.0
—
—
—
0
0
5
27
1.86
0.68
1.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
27
1.86
0.68
1.2
1.3
—
—
—
0
0
104
918
1.15
0.66
1.4
1.5
—
—
—
0
0
5
29
1.73
0.64
2.6
3.0
28.6
30.3
umol/l
—
5
21
5
29
1.73
0.64
2.0
1.5
—
—
—
0
0
20
147
1.37
0.62
1.8
1.3
0.0
0.0
g/l
0.00
15
137
17
233
0.72
0.61
1.5
1.9
3.1
3.3
mg/l
—
8
174
8
51
1.57
0.60
1.9
1.3
—
—
—
0
0
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
8
52
1.54
0.59
2.5
1.8
—
—
—
0
0
20
150
1.34
0.56
1.8
1.3
0.0
0.0
g/l
0.00
15
138
13
90
1.45
0.55
1.2
1.1
—
—
—
0
0
21
160
1.32
0.54
3.0
1.3
0.0
0.0
g/l
0.50
16
148
35
289
1.22
0.49
3.0
3.3
52.2
48.3
%
0.38
35
284
7
46
1.53
0.48
2.4
1.2
—
—
—
0
0
7
46
1.53
0.48
2.4
1.2
—
—
—
0
0
7
46
1.53
0.48
2.4
1.2
—
—
—
0
0
186
1737
1.09
0.47
4.8
3.7
22.1
24.5
%
1.16
75
790
7
47
1.49
0.47
1.1
1.1
—
—
—
0
0
7
47
1.49
0.47
1.1
1.1
—
—
—
0
0
7
47
1.49
0.47
1.1
1.1
—
—
—
0
0
36
300
1.21
0.47
4.8
3.1
4.5
4.6
pmol/l
0.28
28
260
22
174
1.27
0.45
1.5
1.2
2.6
6.4
u/ml
—
5
29
5
31
1.62
0.43
1.6
1.4
—
—
—
0
0
5
31
1.62
0.43
1.2
1.3
—
—
—
0
0
25
203
1.24
0.42
1.8
2.1
—
—
—
0
0
16
206
0.77
0.42
1.5
1.8
—
—
—
0
0
5
34
1.47
0.40
3.0
2.1
40.0
56.7
umol/l
—
5
26
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
5
35
1.43
0.39
1.2
1.2
—
—
—
0
0
21
169
1.25
0.39
2.0
1.8
—
—
—
0
0
85
777
1.11
0.35
1.5
1.4
—
—
—
0
0
11
82
1.35
0.34
1.4
1.3
—
—
—
0
0
218
2080
1.07
0.33
3.8
4.0
18.9
8.7
mg/mmol
0.52
130
1297
17
139
1.23
0.29
1.5
1.3
205.9
243.5
miu/ml
—
7
68
10
76
1.32
0.28
1.1
1.1
0.7
1.2
u/ml
—
5
30
146
1384
1.07
0.28
3.5
3.9
1.0
1.0
kg/l
0.56
30
195
17
140
1.22
0.27
3.8
3.2
0.8
0.8
nmol/l
0.19
12
110
71
656
1.09
0.26
1.5
1.8
1.4
1.5
%
1.25
54
571
5
75
0.66
0.26
1.4
1.3
—
—
—
0
0
9
73
1.24
0.25
1.4
1.4
—
—
—
0
0
38
340
1.12
0.25
1.3
1.5
—
—
—
0
0
161
1681
0.95
0.23
1.8
1.6
1.3
1.4
mmol/l
0.28
130
1406
150
1568
0.95
0.23
3.7
3.8
0.0
0.0
estimate
0.69
39
487
15
125
1.20
0.22
2.3
2.5
3.3
3.6
g/l
0.44
15
118
11
135
0.81
0.22
3.0
4.0
31.2
25.4
mg/l
—
6
91
0
11
0.00
0.21
0.0
1.0
—
26.0
—
0
11
0
12
0.00
0.21
0.0
2.0
—
1.2
—
0
12
12
145
0.82
0.21
1.9
1.5
—
—
—
0
0
26
230
1.13
0.21
1.7
1.9
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
43
469
0.91
0.20
1.8
1.8
—
—
—
0
0
6
48
1.25
0.20
1.2
1.5
—
22.4
—
0
9
25
222
1.13
0.19
1.6
1.6
—
121.8
—
0
11
10
82
1.22
0.17
2.1
1.4
—
—
—
0
0
5
66
0.76
0.17
1.0
1.1
—
—
—
0
0
5
66
0.76
0.17
1.0
1.6
—
—
—
0
0
5
69
0.72
0.17
1.2
1.4
—
—
—
0
0
234
2281
1.04
0.16
3.5
3.7
—
—
—
0
0
11
92
1.20
0.16
1.5
1.3
—
—
—
0
0
57
606
0.94
0.16
3.0
2.9
—
—
—
0
0
9
79
1.14
0.15
1.1
1.2
—
108.0
—
0
13
46
430
1.07
0.15
3.6
2.5
1.2
1.2
mmol/l
0.74
40
354
25
274
0.91
0.14
1.8
1.3
—
—
—
0
0
8
97
0.82
0.13
1.8
1.7
—
—
—
0
0
125
1214
1.04
0.11
3.3
2.7
0.8
0.8
ug/l
0.15
71
798
6
55
1.09
0.09
1.0
1.2
—
—
—
0
0
5
65
0.77
0.08
1.0
1.1
—
—
—
0
0
5
65
0.77
0.08
2.2
3.6
—
—
—
0
0
45
431
1.05
0.08
2.8
2.4
—
21.6
—
0
16
15
137
1.10
0.07
1.3
1.3
—
—
—
0
0
7
81
0.86
0.07
1.4
1.4
—
—
—
0
0
9
85
1.06
0.07
1.1
1.0
—
—
—
0
0
10
89
1.13
0.07
1.2
1.2
—
—
—
0
0
105
1028
1.02
0.06
1.3
1.3
6.3
12.0
u/ml
0.56
35
400
9
100
0.90
0.06
4.6
3.5
54.0
58.7
%
—
9
100
496
4932
1.02
0.06
20.4
14.8
13.7
13.6
%
0.96
490
4810
20
188
1.07
0.05
1.7
1.8
—
—
—
0
0
109
1076
1.02
0.03
1.3
1.3
18.1
33.8
iu/ml
3.05
34
337
17
166
1.02
0.00
1.3
1.2
—
—
—
0
0
17
166
1.02
0.00
1.4
1.5
—
—
—
0
0
17
166
1.02
0.00
1.3
1.2
—
—
—
0
0
12
117
1.03
0.00
1.7
1.3
—
—
—
0
0
12
117
1.03
0.00
1.7
1.3
—
—
—
0
0
17
173
0.98
0.00
2.2
2.3
51.9
86.1
ug/min
—
9
106
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
15
151
0.99
0.00
2.9
2.5
0.3
0.4
u/ml
—
10
93
38
381
1.00
0.00
1.2
1.2
180.5
114.4
iu/ml
—
8
159
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
8
83
0.96
0.00
1.6
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
65.4
—
0
5
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
9
95
0.95
0.00
1.1
1.2
—
—
—
0
0
7
73
0.96
0.00
1.6
1.5
—
—
—
0
0
5
53
0.94
0.00
7.6
2.5
14.2
13.3
%
—
5
53
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
7
77
0.91
0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
7
73
0.96
0.00
1.6
1.5
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
7
73
0.96
0.00
1.6
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
5
54
0.93
0.00
1.2
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_LIP_EXALLC – Benign neoplasm: Lip
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).